Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Establishment method of animal model of Pseudomonas aeruginosa infection pneumonia

A technology of Pseudomonas aeruginosa and animal models, applied in the fields of pharmaceutical formulation, compound screening/testing, medical raw materials derived from bacteria, etc., can solve the epidemic situation that cannot represent PA strains, it is difficult to carry out experiments in large quantities, and experimental animals die and other issues to achieve the effect of avoiding the death of experimental animals, representativeness, and easy infection conditions

Active Publication Date: 2019-06-07
CHENGDU OLYMVAX BIOPHARM +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still big problems in these methods, which are mainly reflected in the following aspects: 1. Although the method of incision of the trachea can guarantee the infection dose, as an invasive method, it is easy to cause damage to the animal organs during the operation and even lead to experimental failure. The animal died; 2. The operation is complicated, and each mouse needs to be operated on, so it is difficult to carry out experiments in large quantities; 3. The Pseudomonas aeruginosa strain used in the reported infection model is the standard strain PA01 from the United States, which cannot represent Epidemiological situation of popular PA strains in China

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Establishment method of animal model of Pseudomonas aeruginosa infection pneumonia
  • Establishment method of animal model of Pseudomonas aeruginosa infection pneumonia
  • Establishment method of animal model of Pseudomonas aeruginosa infection pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1: preparation of Pseudomonas aeruginosa bacterium liquid

[0039] Take the frozen Pseudomonas aeruginosa clinical strain XN-1, revive it with LB nutrient agar plate, and culture it aerobically at 37°C overnight. Pick a single colony and inoculate 20 mL of LB liquid medium, and incubate with aerobic shaking at 180 rpm for 15 hours at 37°C, then inoculate 0.2 mL into 20 mL of LB liquid medium, and culture with aerobic shaking at 230 rpm for 6 hours at 37°C. The cells were collected by centrifugation at 6000g, washed twice with normal saline, and then resuspended with normal saline. The OD of the bacterial solution was measured by a spectrophotometer 600 Value, and adjust the OD value to 1.0 with normal saline, through serial dilution, and count on LB plates to obtain Pseudomonas aeruginosa at OD=1.0 when it is 6.0×10 9 CFU / ml.

Embodiment 2

[0040] Example 2: Establishment of mouse anesthesia and nasal drop scheme

[0041]In the infection experiment of the Pseudomonas aeruginosa pneumonia model, in order to ensure the smooth progress of the nasal drip process, the mice were first anesthetized with isoflurane. Anesthesia method: Inhalation induction anesthesia with 5% isoflurane using oxygen as the transport carrier, and maintain anesthesia with 3% concentration after the mice enter the surgical deep anesthesia period, this method can achieve better anesthesia effect. The control of the nasal drop dose is the guarantee of the stability of the model. In order to better control the nasal drop dose and prevent the bacterial liquid from entering the mouth and generating air bubbles during the nasal drop process, the following measures have been taken: (1) Since the nasopharynx has a physiological The more the head is tilted, the easier it is for nasal drops to enter the mouth. Therefore, during the nasal dripping proce...

Embodiment 3

[0042] Example 3: Determination of Infection Dose

[0043] Physiological saline was used to adjust the PA XN-1 bacterial solution obtained in Example 1 to five different concentrations, and the experimental animal female BALB / c mice were randomly divided into 5 groups. After the mice were anesthetized with isoflurane, the nasal drops were used For infection, the infection dose for each mouse was 20 μL, and the same dose of normal saline (NS) was used as a blank control. The grouping and infection status of the animals are shown in Table 1. After the infection, the death of the mice was observed every other day, and the observation period was 7 days. After the observation period, the remaining animals were treated with CO 2 Euthanized by inhalation.

[0044] Table 1: Determination of Infection Dose in Pseudomonas Aeruginosa Pneumonia Model

[0045] Group

[0046] When adopting the Pseudomonas aeruginosa bacterial strain PA XN-1 infection BALB / c mouse of different c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for establishing a pseudomonas aeruginosa infectious pneumonia animal model. The method comprises the following steps: 1) deeply anesthetizing a mouse by adopting isoflurane; and 2) dripping nose of the mouse with pseudomonas aeruginosa, so that a pseudomonas aeruginosa infectious pneumonia model is established. The method provided by the invention has the advantages that the mouse can be effectively infected, and the pseudomonas aeruginosa pneumonia model is successfully established; and the mouse model after infection is stable and can be applied to evaluation of vaccines and research of protective mechanisms.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a method for establishing an animal model of Pseudomonas aeruginosa infection pneumonia. Background technique [0002] Pseudomonas aeruginosa (PA), commonly known as Pseudomonas aeruginosa, is a non-fermenting bacteria of the genus Pseudomonas, widely distributed in nature, normal human skin, intestinal tract, respiratory tract, and in hospital wards and medical equipment It is also ubiquitous and is one of the most common opportunistic pathogens in clinical practice. At present, the bacterium has become one of the pathogenic bacteria with the highest isolation rate in ICU wards, burns, war wound infections, and mechanical ventilation-associated pneumonia (VAP) worldwide. PA infection can occur in any part and tissue of the human body, such as burns or trauma, middle ear, cornea, urethra, and respiratory tract, etc., and can also cause systemic infections such as endocarditis, gastr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K49/00A61K35/74
CPCA61K35/74A61K49/0008
Inventor 顾江杨峰章金勇邹全明彭六生赵莉群敬海明王逸麟秦溢
Owner CHENGDU OLYMVAX BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com